Identification and quantification of 30 antipsychotics in blood using LC‐MS/MS
- 20 July 2010
- journal article
- research article
- Published by Wiley in Journal of Mass Spectrometry
- Vol. 45 (8) , 915-925
Abstract
Over the last decade, the prescription rates of antipsychotic (AP) drugs have increased worldwide. Studies have shown that the risk of sudden cardiac death is threefold higher among patients treated with APs. To investigate the presence of APs in postmortem cases, a liquid chromatography (LC)‐MS/MS method was developed using only 0.1 ml of blood sample with 10 µl of internal standard (IS) (haloperidol‐d4, 1 µg/ml). After the addition of 0.2 ml of Trizma buffer, the blood sample was extracted using liquid–liquid extraction (LLE) with 1 ml of 1‐chlorobutane for 5 min on a shaker at 1500 rpm. After centrifugation at 12 000 rpm for 1 min, the separated solvent layer was transferred to an autosampler vial and evaporated to dryness under N2. The residue was reconstituted in 0.05 ml acetonitrile containing 0.1% formic acid, vortexed for 30 s and an additional 0.45 ml of 50 mmol/l ammonium formate pH 3.5 was added and the sample vortexed; 0.1 ml of the final extract was injected into a Shimadzu Prominence HPLC system, with detection of drugs achieved using an Applied Biosystems 3200 Q‐TRAP® LC‐MS/MS system equipped with a Turbo V ion source [electron spray ionization (ESI), multiple reaction monitoring (MRM) mode]. The method has been validated according to international guidelines and was found to be selective for all tested compounds. Calibration was satisfactory for all drugs, except olanzapine, from subtherapeutic to toxic concentrations. The lower limits of quantifications (LLOQs) corresponded to the lowest concentrations used for the calibration curves. With the exception of the lowest concentrations of bromperidol, buspirone and perphenazine, accuracy data were within the acceptance interval of ± 15% ( ± 20% at LLOQ) of the nominal values for all drugs. The method has been proven to be useful for the routine analysis of APs in postmortem blood samples. Copyright © 2010 John Wiley & Sons, Ltd.Keywords
This publication has 22 references indexed in Scilit:
- Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac DeathNew England Journal of Medicine, 2009
- Simple and simultaneous determination for 12 phenothiazines in human serum by reversed-phase high-performance liquid chromatographyJournal of Chromatography B, 2007
- Simultaneous analysis of classical neuroleptics, atypical antipsychotics and their metabolites in human plasmaAnalytical and Bioanalytical Chemistry, 2007
- Trends in Antipsychotic Prescribing in Schizophrenia in AucklandAustralasian Psychiatry, 2006
- Trends in Prescribing of Antipsychotic Medications for US ChildrenAcademic Pediatrics, 2006
- Datapoints: Antipsychotic Prescribing Trends Among Youths, 1997-2002Psychiatric Services, 2005
- Antipsychotics and the Risk of Sudden Cardiac DeathArchives of internal medicine (1960), 2004
- Changes in antipsychotic drug prescribing by general practitioners in the United Kingdom from 1991 to 2000: a population‐based observational studyBritish Journal of Clinical Pharmacology, 2003
- High-performance liquid chromatographic method with diode array detection to identify and quantify atypical antipsychotics and haloperidol in plasma after overdoseJournal of Chromatography B, 2003
- Antipsychotics and the Risk of Sudden Cardiac DeathArchives of General Psychiatry, 2001